Saskatoon Berry on Metabolism and Gut Microbiota in Healthy Subjects
Launched by UNIVERSITY OF MANITOBA · Mar 18, 2021
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This clinical trial is looking into the effects of Saskatoon berry on metabolism and gut health in healthy adults. Previous studies have shown that Saskatoon berry may help lower blood sugar levels and improve insulin response in mice, which suggests it could be beneficial for people at risk of developing type 2 diabetes. In this trial, researchers want to see if taking freeze-dried Saskatoon berry can have similar positive effects on glucose metabolism and gut bacteria in people.
To participate, you need to be a healthy adult living in Winnipeg, aged between 18 and 65. You will need to agree to sign a consent form to join the study. However, if you have a history of serious health issues like heart problems, diabetes, or are currently taking certain medications, you won’t be eligible. If you join, you can expect to take the Saskatoon berry supplement and undergo some tests to measure its effects on your body. This study is a great opportunity to contribute to our understanding of how natural foods can support metabolic health!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Healthy subjects living in Winnipeg.
- • 2. Willingness to sign an informed consent.
- Exclusion Criteria:
- • 1. History of myocardial infarction, stroke, hypertension, diabetes, hyperlipidemia, chronic kidney disease.
- • 2) Participants are taking hypoglycemic, anti-hypertensives, lipid lowering medications or antibiotics within a 1 month.
About University Of Manitoba
The University of Manitoba, a leading research institution in Canada, is dedicated to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive expertise in medical research, public health, and community engagement to conduct rigorous and ethical clinical studies. The institution aims to translate scientific findings into practical applications that enhance patient care and improve health outcomes. Committed to fostering a culture of excellence and integrity, the University of Manitoba prioritizes participant safety and scientific validity in all its clinical research endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Winnipeg, Manitoba, Canada
Patients applied
Trial Officials
Garry Shen, PhD
Principal Investigator
University of Manitoba
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials